EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 399 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,517,723 | +48.2% | 156,552 | +56.5% | 0.04% | +33.3% |
| Q1 2024 | $2,373,925 | +153.0% | 100,039 | +155.8% | 0.03% | +135.7% |
| Q4 2023 | $938,345 | +13.0% | 39,114 | +2.9% | 0.01% | +16.7% |
| Q3 2023 | $830,322 | -18.0% | 38,001 | -28.3% | 0.01% | +20.0% |
| Q2 2023 | $1,013,023 | -41.5% | 53,010 | -40.6% | 0.01% | -28.6% |
| Q1 2023 | $1,731,216 | -9.5% | 89,192 | -25.2% | 0.01% | 0.0% |
| Q4 2022 | $1,913,749 | -8.3% | 119,311 | -10.4% | 0.01% | -12.5% |
| Q3 2022 | $2,088,000 | – | 133,191 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |